Test Description

What is Albumin?

Albumin is the most abundant protein in human blood plasma, accounting for approximately 50-60% of total plasma protein.

How is Albumin Produced?

  • Made in the liver: Synthesized exclusively by hepatocytes
  • Production rate: Approximately 12-25 grams per day
  • Key indicator: The liver's ability to produce albumin is one of the most important measures of hepatic synthetic function

How is the Test Performed?

  • Method: Spectrophotometric methods (bromocresol green or bromocresol purple dye binding)
  • Sample: Serum or plasma
  • Preparation: No special patient preparation required

Physiological Functions of Albumin

  • Oncotic Pressure Maintenance: Albumin is the primary determinant of plasma oncotic pressure (colloid osmotic pressure), accounting for approximately 80% of this pressure. It maintains intravascular volume by preventing fluid from leaking into extravascular spaces.
  • Transport Protein: Binds and transports numerous substances including hormones (thyroid hormones, cortisol), fatty acids, unconjugated bilirubin, calcium, magnesium, medications (warfarin, phenytoin, many others), and toxins.
  • Antioxidant Properties: Contains free sulfhydryl groups that scavenge reactive oxygen species and protect against oxidative stress.
  • Anti-inflammatory Effects: Modulates immune responses and has anti-inflammatory properties through multiple mechanisms.
  • Buffer Capacity: Contributes to acid-base buffering in blood.

Clinical Utility

Albumin serves as a marker for both liver synthetic function and nutritional status. However, its long half-life of approximately 20 days makes it unsuitable for detecting acute liver injury or recent nutritional changes. Instead, it reflects chronic conditions affecting protein synthesis or loss.

Albumin is commonly used in several clinical calculations including the serum-ascites albumin gradient (SAAG) for ascites evaluation and corrected calcium for patients with hypoalbuminemia.

Quick Reference
  • Normal Range: 3.5-5.5 g/dL
  • SI Units: 35-55 g/L
  • Half-Life: ~20 days
  • Critical Value: <2.0 g/dL
  • Sample Type: Serum or plasma
  • Key Point: Marker of hepatic synthetic function and nutritional status
Normal Ranges

Albumin levels are relatively consistent across populations with minimal variation by sex. Age-related changes occur, with slightly higher values in younger adults and gradual decline in elderly populations.

Swipe to see more
Population Normal Range (g/dL) SI Units (g/L)
Adults (18-60 years) 3.5-5.5 35-55
Elderly (>60 years) 3.2-4.8 32-48
Neonates 2.5-4.5 25-45
Pregnancy (3rd trimester) 2.5-4.5 25-45

Important Considerations

Normal ranges may vary between laboratories depending on the assay method used (bromocresol green vs. bromocresol purple). Always use laboratory-specific reference ranges.

  • Bromocresol green (BCG): May overestimate albumin, especially in critically ill patients, by binding to other proteins
  • Bromocresol purple (BCP): More specific for albumin, considered the gold standard
  • Position during blood draw: Prolonged tourniquet application or upright position can falsely elevate albumin by 5-10%
  • Hemodilution/concentration: IV fluid administration or dehydration significantly affects measured values
Clinical Significance

Hypoalbuminemia (Low Albumin)

Hypoalbuminemia is defined as serum albumin <3.5 g/dL. It is a common finding in hospitalized patients and associated with increased morbidity and mortality. The causes can be categorized by mechanism: decreased synthesis, increased loss, or redistribution.

Decreased Synthesis (Hepatic Causes)

  • Chronic liver disease: Cirrhosis, chronic hepatitis - albumin falls as synthetic function declines. Included in Child-Pugh score for cirrhosis severity.
  • Acute liver failure: Severe acute hepatocellular injury, though short half-life limits utility in acute settings
  • Advanced hepatocellular carcinoma: When sufficient liver parenchyma is replaced by tumor

Decreased Synthesis (Nutritional Causes)

  • Malnutrition/Protein-energy malnutrition: Kwashiorkor (protein deficiency with adequate calories), marasmus (combined protein-calorie deficiency)
  • Malabsorption syndromes: Celiac disease, inflammatory bowel disease, short bowel syndrome
  • Anorexia nervosa: Chronic caloric and protein restriction
  • Cachexia: Cancer, AIDS, chronic heart failure, COPD - cytokine-mediated muscle wasting

Increased Loss

  • Nephrotic syndrome: Massive proteinuria (>3.5 g/day) with urinary albumin loss exceeding hepatic synthesis capacity
  • Protein-losing enteropathy: Inflammatory bowel disease, lymphatic obstruction, celiac disease - GI loss of protein
  • Burns/wound exudates: Large body surface area burns or extensive wounds with protein-rich exudate
  • Hemorrhage: Significant blood loss results in albumin loss

Redistribution and Inflammation

  • Sepsis and critical illness: Capillary leak syndrome with albumin redistribution to extravascular space, plus decreased synthesis from negative acute phase response
  • Acute inflammation: Albumin is a negative acute phase reactant - synthesis decreases during inflammation as liver prioritizes positive acute phase proteins
  • Ascites and third-spacing: Redistribution into peritoneal, pleural, or interstitial spaces
  • Volume overload/dilution: Aggressive IV fluid resuscitation, heart failure, SIADH causing hemodilution

Hyperalbuminemia (High Albumin)

True hyperalbuminemia is extremely rare. Elevated albumin values almost always represent pseudohyperalbuminemia due to hemoconcentration rather than increased production.

Causes of Elevated Albumin

  • Dehydration/Volume depletion: The most common cause - severe dehydration, vomiting, diarrhea causing hemoconcentration
  • Prolonged tourniquet application: Technical artifact from venipuncture technique
  • Upright posture during blood draw: Postural changes causing fluid shifts
  • High-dose IV albumin infusion: Iatrogenic elevation following albumin administration

Clinical Context

Albumin rarely exists in isolation. Always interpret in context of:

  • Clinical presentation and history
  • Other liver function tests (AST, ALT, bilirubin, PT/INR)
  • Markers of inflammation (CRP, ESR)
  • Nutritional assessment
  • Renal function and urinalysis (to assess for proteinuria)
  • Volume status and IV fluid administration
Interpretation Guidelines

Severity Classification of Hypoalbuminemia

Swipe to see more
Severity Albumin Level (g/dL) Clinical Features
Mild 3.0-3.4 Often asymptomatic; may have subtle edema
Moderate 2.5-2.9 Peripheral edema, increased infection risk
Severe <2.5 Ascites, anasarca, high mortality risk, pleural effusions
Critical <2.0 Life-threatening; massive edema, coagulopathy risk, very high mortality

Serum-Ascites Albumin Gradient (SAAG)

The SAAG is used to determine the cause of ascites by measuring the difference between serum and ascitic fluid albumin concentrations. It has superior accuracy to older classification systems.

SAAG Calculation
SAAG = Serum Albumin - Ascitic Fluid Albumin

Interpretation:
SAAG ≥1.1 g/dL = Portal hypertension (97% accuracy)
SAAG <1.1 g/dL = Non-portal hypertensive causes

SAAG ≥1.1 g/dL (Portal Hypertension)

  • Cirrhosis (most common)
  • Alcoholic hepatitis
  • Cardiac ascites (right heart failure, constrictive pericarditis)
  • Budd-Chiari syndrome (hepatic vein thrombosis)
  • Sinusoidal obstruction syndrome (veno-occlusive disease)
  • Massive liver metastases

SAAG <1.1 g/dL (Non-Portal Hypertensive)

  • Peritoneal carcinomatosis
  • Tuberculous peritonitis
  • Pancreatic ascites
  • Nephrotic syndrome
  • Serositis (lupus, connective tissue disease)
  • Bowel perforation or infarction

Corrected Calcium

Approximately 40-50% of total serum calcium is bound to albumin. When albumin is low, total calcium appears falsely low even if ionized (active) calcium is normal. The corrected calcium formula estimates what the total calcium would be if albumin were normal.

Corrected Calcium Formula
Corrected Calcium (mg/dL) = Measured Total Calcium + 0.8 × (4.0 - Measured Albumin)

Where 4.0 g/dL is the assumed normal albumin. Each 1 g/dL decrease in albumin decreases total calcium by ~0.8 mg/dL.

Limitations of Corrected Calcium

Corrected calcium is an estimate and may be inaccurate in:

  • Severe hypoalbuminemia (<2.0 g/dL)
  • Acid-base disturbances (affect calcium-albumin binding)
  • Critically ill patients
  • Multiple myeloma (paraproteins interfere)

When in doubt, measure ionized calcium directly - this is the gold standard for assessing calcium status.

Albumin in Prognostic Scoring Systems

Albumin is incorporated into several clinical scoring systems for liver disease:

Child-Pugh Score (Cirrhosis Severity)

  • 3 points: Albumin >3.5 g/dL
  • 2 points: Albumin 2.8-3.5 g/dL
  • 1 point: Albumin <2.8 g/dL

Combined with bilirubin, INR, ascites, and encephalopathy to classify cirrhosis as Child-Pugh class A (5-6 points), B (7-9 points), or C (10-15 points).

MELD Score (Model for End-Stage Liver Disease)

While MELD uses creatinine, bilirubin, and INR, it does NOT include albumin. MELD-Na (updated version) adds sodium but still excludes albumin. However, albumin independently predicts mortality in cirrhosis beyond MELD score.

Interfering Factors

Factors That Falsely Increase Albumin

  • Dehydration/Hemoconcentration: Vomiting, diarrhea, inadequate fluid intake causing volume depletion
  • Prolonged tourniquet application: >1 minute tourniquet time can increase albumin by 5-10%
  • Upright position: Postural changes cause fluid shifts; sitting vs. supine can alter values
  • Assay interference (BCG method): Bromocresol green method can overestimate albumin by binding to other proteins, especially globulins
  • Recent IV albumin infusion: Exogenous albumin administration
  • Sample hemolysis: May interfere with some assay methods

Factors That Falsely Decrease Albumin

  • IV fluid administration: Hemodilution from crystalloid or colloid infusion
  • Pregnancy: Physiologic hemodilution, especially third trimester
  • Supine position during blood draw: Compared to upright position
  • Sample standing time: Prolonged storage before analysis may affect some methods

Medications Affecting Albumin Levels

  • Decrease albumin synthesis:
    • Amiodarone (hepatotoxicity)
    • Methotrexate (hepatotoxicity)
    • Oral contraceptives (mild decrease, estrogen effect)
    • Any hepatotoxic medication (acetaminophen overdose, isoniazid, etc.)
  • Increase urinary albumin loss:
    • NSAIDs (can cause nephrotic syndrome)
    • ACE inhibitors (initially may increase proteinuria, though long-term renoprotective)
    • Lithium (nephrogenic diabetes insipidus, potential nephrotic syndrome)
  • Affect protein binding:
    • High-dose penicillin or cephalosporins (compete for albumin binding sites)
    • Salicylates (compete for binding sites)

Physiologic Variables

  • Age: Albumin decreases with age; elderly often have albumin 3.2-4.5 g/dL as normal
  • Circadian variation: Minimal (unlike some proteins); albumin relatively stable throughout day
  • Exercise: Strenuous exercise can cause transient hemoconcentration and mild elevation
  • Inflammation/Acute phase response: Any acute or chronic inflammatory condition decreases albumin synthesis as a negative acute phase reactant

Pre-analytical Errors

  • Incorrect tube type: Though albumin stable in most tube types
  • Sample contamination: IV fluid contamination from line draws
  • Incomplete clotting: Fibrin strands may interfere with analysis
  • Lipemia: High triglycerides may interfere with spectrophotometric methods
Clinical Pearls
  • "Low albumin doesn't always mean liver disease": Hypoalbuminemia is common in hospitalized patients due to inflammation, malnutrition, volume overload, or renal/GI losses. Always consider the clinical context and rule out non-hepatic causes before attributing low albumin to liver dysfunction.
  • "The 20-day rule": With a half-life of approximately 20 days, albumin takes 60-100 days to reach a new steady state after changes in synthesis. This makes it useless for acute liver injury (use INR/PT instead) but excellent for assessing chronic liver disease or nutritional status over weeks to months.
  • "SAAG beats the old system": The serum-ascites albumin gradient (SAAG ≥1.1 g/dL = portal hypertension) has 97% accuracy and replaced the outdated exudate/transudate classification (which was based on Light's criteria designed for pleural effusions, not ascites).
  • "Albumin is a negative acute phase reactant": During any acute illness, inflammation, or infection, the liver prioritizes production of positive acute phase proteins (CRP, ferritin, fibrinogen) and decreases albumin synthesis. This is why ICU patients commonly have low albumin even without liver disease or malnutrition - it's part of the stress response.
  • "Don't reflexively replace low albumin": IV albumin replacement is expensive, short-lived (redistributes rapidly), and only indicated for specific conditions: large-volume paracentesis (>5L removed), hepatorenal syndrome, spontaneous bacterial peritonitis in some cases, and occasionally nephrotic syndrome. It's NOT indicated for nutritional repletion or to "boost" a low number without clear clinical benefit.
  • "Use ionized calcium when albumin is abnormal": The corrected calcium formula is a rough estimate. When albumin is <2.0 g/dL or >5.0 g/dL, or in critically ill patients with acid-base disturbances, order ionized calcium directly - it's the definitive test for calcium status and eliminates guesswork.
  • "Cirrhosis trinity - albumin, bilirubin, INR": These three markers assess the liver's critical synthetic functions. Unlike AST/ALT (which measure hepatocyte injury), these tests measure what the liver actually does: make proteins (albumin, clotting factors) and conjugate bilirubin. All three are incorporated into Child-Pugh scoring.
  • "The edema threshold": Clinically significant edema typically doesn't appear until albumin drops below 2.5-3.0 g/dL. The oncotic pressure gradient becomes insufficient to retain fluid in vasculature. However, other factors (heart failure, renal dysfunction, medications) can cause edema with normal albumin.
  • "Rule out the simple causes first": When faced with hypoalbuminemia, check urinalysis for proteinuria (nephrotic syndrome), assess volume status and recent IV fluids (dilution), review medication list (hepatotoxins), and consider CRP/ESR (inflammation) before assuming chronic liver disease or malnutrition.
  • "Albumin predicts mortality independently": In multiple studies across different disease states (sepsis, cirrhosis, heart failure, malignancy), low albumin independently predicts increased mortality even after adjusting for other factors. Each 1 g/dL decrease is associated with 24-56% increase in mortality depending on the population.
  • "BCG vs BCP controversy": Many labs still use bromocresol green (BCG) method which overestimates albumin, especially in critically ill patients. If your ICU patient has a surprisingly "normal" albumin despite obvious critical illness, consider that it may be falsely elevated by the assay. Bromocresol purple (BCP) is more accurate but less widely available.
  • "Pre-albumin is NOT a mini-albumin": Despite the name, prealbumin (transthyretin) is a completely different protein. With a half-life of 2-3 days vs. albumin's 20 days, prealbumin is more sensitive for acute nutritional changes or acute phase response. However, it's also a negative acute phase reactant, limiting its use in inflamed/infected patients.
  • "Volume status check before interpretation": Always assess the patient's volume status. A patient with anasarca and massive volume overload may have a low albumin that's 50% real and 50% dilutional. Conversely, a dehydrated patient with normal albumin might have underlying hypoalbuminemia masked by hemoconcentration.
  • "Nephrotic syndrome = massive albuminuria": If albumin is low and urinalysis shows 3-4+ protein, think nephrotic syndrome. The classic tetrad is: proteinuria >3.5 g/day, hypoalbuminemia, edema, and hyperlipidemia. The kidneys can lose more albumin than the liver can make, leading to progressive hypoalbuminemia.
References
  1. Kratz, A., Ferraro, M., Sluss, P. M., & Lewandrowski, K. B. (2004). Laboratory reference values. New England Journal of Medicine, 351, 1548-1564.
  2. Lee, M. (Ed.). (2009). Basic skills in interpreting laboratory data. Ashp.
  3. Farinde, A. (2021). Lab values, normal adult: Laboratory reference ranges in healthy adults. Medscape. https://emedicine.medscape.com/article/2172316-overview?form=fpf
  4. Nickson, C. (n.d.). Critical Care Compendium. Life in the Fast Lane • LITFL. https://litfl.com/ccc-critical-care-compendium/
  5. Farkas, Josh MD. (2015). Table of Contents - EMCrit Project. EMCrit Project. https://emcrit.org/ibcc/toc/
Back to Liver Panel All Lab Values
Medical Disclaimer
  • For Educational Purposes Only: This content is intended for educational reference and should not be used for clinical decision-making.
  • Not a Substitute for Professional Judgment: Always consult your local protocols, institutional guidelines, and supervising physicians.
  • Verify Before Acting: Users are responsible for verifying information through authoritative sources before any clinical application.
AI Assistance Notice
The clinical content and references are curated and reviewed by myself; however, AI was used to assist in organizing, paraphrasing, and formatting the information presented.